Abstract
Background and hypothesis
Extended-hours haemodialysis (HD) is associated with better clinical outcomes than conventional HD. We investigated whether extended-hours HD and conventional HD have varying effects on blood levels of calciprotein particles (CPPs) and phosphorus, which have been identified as major pathogenic molecules for vascular calcification.Methods
Patients who underwent conventional or extended in-centre daytime HD between January and March 2020 were included. Plasma CPP levels, representing only secondary CPPs (CPP-II), were measured in pre-dialysis samples. Linear and non-linear associations between CPPs and serum phosphorus levels were examined across dialysis modalities.Results
A total of 382 participants (185 undergoing extended-hours HD and 197 undergoing conventional HD) were included in the analysis. The median age of participants was 71 years, 65% of the patients were men and the mean phosphorus level was 5.4 mg/dl. Plasma CPP (CPP-II) levels were lower in the extended-hours HD group than in the conventional HD group [40 018 (arbitrary units) AU versus 75 728 AU; P < .01]. Multivariable linear regression analysis showed that extended-hours HD was associated with lower natural logarithmic plasma CPP (CPP-II) levels: -0.64 (95% confidence interval -0.74 to -0.55). A restricted cubic spline function indicated that extended-hours HD was associated with lower plasma CPP (CPP-II) levels across levels of serum phosphorus, with significant differences observed between groups, especially in hyperphosphataemic conditions (P for interaction <.01).Conclusions
The extended-hours HD group had lower CPP levels than the conventional HD group despite no significant differences in serum phosphorus levels, which may contribute to better clinical outcomes in patients on extended-hours HD.References
Articles referenced by this article (35)
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.
Am J Kidney Dis, (4):607-617 1998
MED: 9531176
Impact of aortic stiffness on survival in end-stage renal disease.
Circulation, (18):2434-2439 1999
MED: 10318666
Klotho and calciprotein particles as therapeutic targets against accelerated ageing.
Clin Sci (Lond), (15):1915-1927 2021
MED: 34374422
Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.
Ther Apher Dial, (3):247-288 2013
MED: 23735142
Prescribed dietary phosphate restriction and survival among hemodialysis patients.
Clin J Am Soc Nephrol, (3):620-629 2010
MED: 21148246
The association between intensive care unit-acquired hypernatraemia and mortality in critically ill patients with cerebrovascular diseases: a single-centre cohort study in Japan.
BMJ Open, (8):e016248 2017
MED: 28821524
Mid-term predictive value of calciprotein particles in maintenance hemodialysis patients based on a gel-filtration assay.
Atherosclerosis, 46-52 2020
MED: 32307113
Serum phosphate levels and mortality risk among people with chronic kidney disease.
J Am Soc Nephrol, (2):520-528 2004
MED: 15615819
Nonlinear modeling was applied thoughtfully for risk prediction: the Prostate Biopsy Collaborative Group.
J Clin Epidemiol, (4):426-434 2014
MED: 25777297
Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles.
J Biol Chem, (15):13333-13341 2003
MED: 12556469
Show 10 more references (10 of 35)
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.
Am J Kidney Dis, 77(3):346-354, 13 Aug 2020
Cited by: 11 articles | PMID: 32800846 | PMCID: PMC7881044
Effect of Sevelamer on Calciprotein Particles in Hemodialysis Patients: The Sevelamer Versus Calcium to Reduce Fetuin-A-Containing Calciprotein Particles in Dialysis (SCaRF) Randomized Controlled Trial.
Kidney Int Rep, 5(9):1432-1447, 29 Jun 2020
Cited by: 8 articles | PMID: 32954068 | PMCID: PMC7486191
Effect of lanthanum carbonate on serum calciprotein particles in patients with stage 3-4 CKD-results from a placebo-controlled randomized trial.
Nephrol Dial Transplant, 38(2):344-351, 01 Feb 2023
Cited by: 1 article | PMID: 35212735 | PMCID: PMC9923701
Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
Am J Kidney Dis, 68(5s1):S24-S32, 01 Nov 2016
Cited by: 20 articles | PMID: 27772640
Review